Literature DB >> 16970896

Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child.

Ilknur Erol1, Füsun Alehan, Kizbes Yalçin.   

Abstract

Human parvovirus B19 is the agent that causes erythema infectiosum (fifth disease), a disease that is generally benign and self-limiting. This virus also is associated with severe disease in hemolytic or immunocompromised patients. It rarely causes meningoencephalitis in healthy children. Herein we present the case of a 10-year-old healthy girl with refractory status epilepticus possibly owing to human parvovirus B19 encephalitis who was successfully treated with high-dose corticosteroids. To our knowledge, this is the first report of human parvovirus B19 encephalitis complicated by refractory status epilepticus in a child.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970896     DOI: 10.1177/08830738060210092301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Focal seizure associated with human parvovirus B19 infection in a non-encephalopathic child.

Authors:  Debopam Samanta; Erin Willis
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

2.  Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs.

Authors:  J Kalita; P P Nair; U K Misra
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

Review 3.  Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children.

Authors:  Toru Watanabe; Hideshi Kawashima
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 4.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

Review 5.  Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review.

Authors:  Judith N Wagner; Annette Leibetseder; Anna Troescher; Juergen Panholzer; Tim J von Oertzen
Journal:  J Neurol       Date:  2021-03-06       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.